Tranexamic acid for the treatment of significant traumatic brain injury: an international randomised, double blind placebo controlled trial
Not Applicable
- Conditions
- Traumatic Brain Injury
- Registration Number
- JPRN-UMIN000017980
- Lead Sponsor
- ondon School of Hygiene & Tropical Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
1)significant extra cranial bleeding (needing immediate blood transfusion) 2) antifibrinolytic agents in a patient
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome is death in hospital within 28 days of injury (cause-specific mortality will also be recorded)
- Secondary Outcome Measures
Name Time Method